ASAM eLearning
Pain Management & Opioids: Balancing Risks & Benefits - Updated (2.5 CME)
-
Register
- Non-Member - Free!
- Regular Member - Free!
- Retired - Free!
- Early Career Physician - Free!
- Resident - Free!
- Student - Free!
- Associate - Free!
- ASAM Staff - Free!
- International Member - Free!
- Emeritus Member - Free!
- Provisional Member - Free!
- Fellow Member - Free!
- Honorary Member - Free!
- CRT Member - Free!
The misuse of opioids is a major public health problem. Centers for Disease Control and Prevention reported the following:
- From 1999 to 2016 more than 630,000 people died from drug overdoses.
- 115 Americans die every day from an opioid overdose.
The CO*RE/ASAM Pain Management and Opioids: Balancing Risks and Benefits curriculum is newly updated to reflect the latest information in this vital area of healthcare. The thoroughly revised curriculum addresses: the nature and pathophysiology of pain; assessing patients in pain; creating a pain treatment plan; initiating opioid therapy; managing patients on opioid analgesics; educating patients and caregivers; and understanding opioid use disorder. This program meets many states requirements for opioid education and is fully compliant with the Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) education requirement (“Blue Print”), issued by the U.S. Food & Drug Administration in September 2018.
Edwin A. Salsitz
MD, DFASAM
Dr. Edwin Salsitz has been an attending physician at Mt. Sinai Beth Israel, Division of Chemical Dependency, in New York City since 1983, and is an Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai. He is the principal investigator of the Methadone Medical Maintenance (office-based methadone maintenance) research project. Dr. Salsitz is certified by the American Board of Addiction Medicine (ABAM) and the Board of Internal Medicine and Pulmonary Disease.
Adam Gordon
MD, MPH, FACP, CMRO, DFASAM
Adam Gordon, MD MPH FACP DFASAM CMRO is the Elbert F. and Marie Christensen Endowed Research Professor of Medicine and Psychiatry at the University of Utah School of Medicine and Chief of Addiction Medicine at the Salt Lake City VA Healthcare System. He is a board certified internal medicine (American Board of Internal Medicine) and addiction medicine physician (American Board of Addiction Medicine) and has received distinction in both fields as a Fellow in the American College of Physicians (FACP) and a Distinguished Fellow in the American Society of Addiction Medicine (DFASAM). Prior to moving to Salt Lake City in the Winter of 2017, he was a Professor of Medicine and Clinical and Translational Sciences and an Advisory Dean in Student Affairs at the University of Pittsburgh School of Medicine. He maintains an active internal medicine – addiction medicine practice and has been honored nationally for his community service and clinical activities.
He has a 17-year track record of conducting clinical, health services, and implementation scienceresearch on the quality, equity, and efficiency of health care for vulnerable populations, including patients with opioid use and other substance disorders and/or who are homeless. Major themes of his current research include the identification and implementation of evidence-based care for patients with addiction disorders and understanding the intersection of pain syndromes, opioid misuse, and engagement into opioid use disorder treatment. He is a prior VA Health Services Research and Development Service Career Development Awardee. His research has been funded by the NIH, VA, AHRQ, PCORI, SAMHSA, among others. He has authored over 150 peer reviewed scientific papers, several books and book chapters, and hundreds of peer reviewed scholarly abstracts, presentations, and other work. He has been recognized with several national research awards for his research, including the Young Investigator of the Year from the Association for Medical Education and Research on Substance Abuse (AMERSA).
His professional career has been noted for service to federal government, community initiatives, and mentoring. For example, he directs the Buprenorphine Initiative in the VA where he leads a national consult service to increase the implementation of medication treatment for opioid use disorder. He is the Director of the National Coordinating Center for the VA Office of Academic Affiliations Advanced Interdisciplinary Fellowship in Addiction Research and Treatment, where he coordinates educational activities for fellowship sites across the country. He serves as the Editor-in-Chief of Substance Abuse, the Board of Directors of the International Society of Addiction Journal Editors, and the Board of Directors of AMERSA. He has had leading positions with several organizations including American Society of Addiction Medicine (ASAM. Chair of Continuing Medical Education), Allegheny County Medical Society (President, Board of Directors), and Pennsylvania Medical Society (Board of Trustees).
As a senior, tenured, faculty member, he is passionate about training the next generation of clinicians and clinical researchers. Apart from this advising of hundreds of medical students in his prior capacity as an Advisory Dean at the University of Pittsburgh, he has educated, trained, or mentored over 50 post-graduate scholars to be leaders in scholarly activities involving addiction treatment. His mentees have received research career development awards, large VA/NIH research grants, and local and national young investigator of the year awards. As a testament to his teaching and mentoring expertise, he was named as one of the inaugural VA Health Services Research and Development (HSR&D) National Mentor Network (MNet) mentors. In addition, he has received of research mentoring awards including from the University of Pittsburgh, the AMA, and AMERSA (2013 W. Anderson Spickard, Jr. Excellence in Mentorship Award).
Adam lives with his wife, Margaret Conroy, MD MPH and children Lillian, Neil, and Martha in Salt Lake City, Utah. He enjoys gardening and tennis.
Credits and Disclosures
ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Society of Addiction Medicine designates this enduring material for a maximum of 2.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.
Maintenance of Certification
American Board of Preventive Medicine (ABPM)
The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 2.5 LLSA credits towards ABPM MOC Part II requirements.
American Board of Anesthesiology (ABA)
This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.
American Board of Pediatrics (ABP)
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 2.5 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.
American Board of Surgery (ABS)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit
American Board of Psychiatry and Neurology (ABPN)
Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.
American Board of Addiction Medicine (ABAM)
Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.
Program Planning Committee
| Name | Commercial Interest | What was received? | For what role? |
| Herbert Malinoff, MD, FACP, DFASAM | None |
|
|
| Yngvild Olsen, MD, MPH | None |
|
|
| Theodore Parran, MD, FACP | None |
|
|
| Edwin Salsitz, MD, DFASAM | None |
|
|
| R. Corey Waller, MD, MS, FACEP | None |
|
|
Faculty Advisory Panel
| Name | Commercial Interest | What was received? | For what role? |
| David Bazzo, MD | None |
|
|
| Ronald Crossno, MD | None |
|
|
| Kate Galluzzi, DO | None |
|
|
| Carol Havens, MD | None |
|
|
| Randy Hudspeth, APRN | None |
|
|
| Dennis Rivenburgh, PA-C | None |
|
|
| Edwin A. Salsitz, MD, DFASAM | None |
|
|
| Barb St. Marie, ANP | None |
|
|
Faculty
| Name | Commercial Interest | What was received? | For what role? |
| Edwin A. Salsitz, MD, DFASAM | None |
|
|
| Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO | None |
|
|
CME Committee Reviewers
| Name | Commercial Interest | What was received? | For what role? |
| Jacob Bobrowski, MD, FAAFP | None |
|
|
| Anthony H. Dekker, DO, DFASAM | None |
|
|
Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information
In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.
Key:
Complete
Next
Failed
Available
Locked